FPRX


Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79%

Amgen has agreed to snap up clinical-stage biotech Five Prime Therapeutics for an equity value of $1.9 billion, to strengthen the company’s oncology …

3 Healthcare Stocks Under $10 With Massive Upside Ahead

Which stocks are leading the pack out on Wall Street? Biotechs.

Biotech Beat: RXi Pharmaceuticals Corp (RXII), Zafgen Inc (ZFGN), Five Prime Therapeutics Inc (FPRX)

RXi Pharmaceuticals Corp On October 15, 2015, RXi Pharmaceuticals Corp (NASDAQ:RXII) announced positive phase 2a results for its RXI-109 compound. The trial, known …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts